A hormone’s route is part of the treatment, not just a cosmetic preference. Swallowing estrogen, absorbing it through the skin and applying a low-dose vaginal product can involve different effects and practical instructions.
There is no route that is best for every person. A useful comparison considers the symptoms, medical history, ability to use the medicine consistently, cost and the evidence for the exact product.
In this entry
Pills: a familiar routine with specific considerations
An oral product may fit easily into an existing medication routine. It also passes through the digestive system and liver, which can affect the risk discussion and interactions. Tell your clinician about other medicines and relevant medical conditions rather than assuming a tablet is the simplest clinical choice.
Do not split, crush or change the timing of a prescription unless the pharmacist or prescriber confirms it is appropriate. A missed-dose question should be answered using the specific product information.
Patches: systemic treatment through the skin
An estradiol patch delivers estrogen transdermally. Some products are changed once weekly and others more often; follow the label for the actual prescription. Adhesion, application-site irritation and access to refills can affect whether the route works well in daily life.
The Menopause Society notes that clot risk may be lower with transdermal than oral estrogen. This is not a guarantee that a patch is appropriate after a previous clot or with another contraindication. A different route cannot replace medical assessment.
Creams and gels: the application site matters
A systemic skin product and a vaginal product can have different purposes even when both are called estrogen cream. Ask where it is applied, what symptoms it targets and whether the finished preparation is approved or compounded.
For topical medicines, ask about drying, bathing and preventing unintended transfer when relevant to the product. Do not apply a body formulation internally or a vaginal preparation elsewhere based on a similar ingredient list.
Keep the uterine-protection plan attached
If you have a uterus and use systemic estrogen, an appropriate progestogen is generally needed. That requirement does not disappear because estrogen is delivered through the skin. A combined compounded cream also needs a specific evidence discussion.
The progesterone guide explains this part of care. A low-dose local vaginal treatment is a different situation, so ask which category your actual prescription falls into.
Plan for changes and shortages
In September 2026 the FDA reported access difficulties involving some estradiol patches. A pharmacist may help find an appropriate alternative, with the prescriber’s involvement when needed. Do not calculate a new route or dose from a comparison chart.
The refill guide covers continuity questions. For service comparisons, Alloy, Winona and Midi illustrate different menus and care models. The right route should come from the clinical discussion, then be matched to a service that can support it.
CHECK THE ORIGINAL
The source record
Provider pages document their own offers. Medical and regulatory sources provide treatment context. This is not a record of personal patient testing. All sources checked September 20, 2026.